2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Systemic Inflammation: new trials by email Literature Review of Systemic Inflammation trials Research Report on Systemic Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I) Single-Dose IV Oritavancin Diphosphate, IV Vancomycin, Placebo - Wound Infection, Abscess | Phase 3 | Completed | Melinta Therapeutics, Inc. | 968 | 2010-12-01 | 2022-08-01 |
| Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection Single-Dose IV Oritavancin Diphosphate, IV Vancomycin - Wound Infection, Abscess | Phase 3 | Completed | Melinta Therapeutics, Inc. | 1019 | 2010-12-01 | 2021-05-05 |
Abscess (2) · Cellulitis (2) · Wound Infection (2)
Connective Tissue Diseases (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases, Infectious (2) · Skin and Connective Tissue Diseases (2) · Suppuration (2)
Vancomycin (2)
Melinta Therapeutics, Inc. (2)
United States (2)